medigraphic.com
ISSN 0016-3813 (Print)

2019, Number 4

<< Back Next >>

Gac Med Mex 2019; 155 (4)

Factores de riesgo para mortalidad en pacientes con infección por Clostridium difficile

Pérez-Cruz E, Sandoval-FMG

Language: Spanish
References: 21
Page: 343-349
PDF size: 164.70 Kb.


ABSTRACT

Introduction: Clostridium difficile infection (CDI) causes potentially lethal diarrhea. Objective: To identify the risk factors for mortality in hospitalized patients with CDI. Method: Cross-sectional, retrospective study. The analyzed risk factors were age, comorbidities, nutritional status, past and current use of antibiotics, proton pump inhibitors, steroids, immunosuppressive therapy and chemotherapy, as well as development of acute kidney injury (AKI). Results: Sixty-eight cases were assessed. Mean age was 51.4 ± 19.37 years. Mortality was 22.2 %. Moderate to severe undernutrition (Odds ratio [OR] = 20.15; 95% confidence interval [CI] = 1.13-35; p = 0.004), use of more than 2 antibiotics (OR = 1.61; 95% CI = 0.39-6.65; p = 0.01), AKI as determined by creatinine levels (OR = 1.34; 95% CI = 0.09-2.21; p = 0.02), hypotension with vasopressor use (OR = 1.28; 95% CI = 0.30-1.23; p = 0.001) and multiple organ failure (OR = 1.13; 95% CI = 0.31-4.92; p = 0.002) were associated with mortality. Conclusions: CDI represents an important problem in hospitalized patients and confers them an additional morbidity and mortality risk.


REFERENCES

  1. Lopardo G, Morfin-Otero R, Morán-Vázquez II, Noriega F, Zambrano B, Luxemburger C, et al. Epidemiology of clostridium difficile: a hospital-based descriptive study in Argentina and Mexico. Braz J Infect Dis. 2015; 19:8-14.

  2. Riddle DJ, Dubberke ER. Clostridium difficile infection in the intensive care unit. Infect Dis Clin North Am. 2009;23:727-743.

  3. Vindigni SM, Surawicz CM. C. difficile infection: changing epidemiology and management paradigms. Clin Transl Gastroenterol. 2015;6:e99.

  4. Lessa FC, Gould CV, McDonald LC. Current status of clostridium difficile infection epidemiology. Clin Infect Dis. 2012;55:S65-S70.

  5. Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B, et al. The changing epidemiology of clostridium difficile infections. Clin Microbiol Rev. 2010;23:529-549.

  6. Carroll KC, Bartlett JG. Biology of clostridium difficile: implications for epidemiology and diagnosis. Annu Rev Microbiol. 2011;65:501-521.

  7. Ramírez-Rosales A, Cantú-Llanos E. Intrahospital mortality in patients with Clostridium difficile-associated diarrhea infection. Rev Gastroenterol Mex. 2012;77:60-65.

  8. Meyer SL, Espinoza AR, Quera PR. Infección por Clostridium difficile: epidemiología, diagnóstico y estrategias terapéuticas. Rev Med Clin. 2014;25: 473-484.

  9. Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S, Turgeon N, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med. 2011;365:1693-1703.

  10. Kazanowski M, Smolarek S, Kinnarney F, Grzebieniak Z. Clostridium difficile: epidemiology, diagnostic and therapeutic possibilities: a systematic review. Tech Coloproctol, 2014;18:223-232.

  11. Steiner C, Barrett M, Weiss A. HCUP Projections: Clostridium difficile hospitalizations 2003-2014. HCUP Projections Report # 2014-03. EE. UU.: Agency for Healthcare Research and Quality; 2014.

  12. Feuerstadt P, Das R, Brandt LJ. The evolution of urban C. difficile infection (CDI): CDI in 2009-2011 is less severe and has better outcomes than CDI in 2006-2008. Am J Gastroenterol. 2014;109:1265-1276.

  13. Dávila LP, Garza-González E, Rodríguez-Zulueta P, Morfín-Otero R, Rodríguez-Noriega E, Vilar-Compte D, et al. Increasing rates of Clostridium difficile infection in Mexican hospitals. Braz J Infect Dis. 2017; 21:530‑534.

  14. DePestel DD, Aronoff DM. Epidemiology of Clostridium difficile infection. J Pharm Pract, 2013;26:464-475.

  15. Monge D, Millán I, González-Escalada A, Asensio A. The effect of Clostridium difficile infection on length of hospital stay. A cohort study. Enferm Infecc Microbiol Clin. 2013;31:660-664.

  16. Velarde-Ruiz-Velasco JA, Aldana-Ledesma JM, Ibarra-Estrada MA, Aguirre- Díaz SA, Fernández-Ramírez JA, Cárdenas-Lara F, et al. Clinical and endoscopic features in patients with hospital-acquired diarrhea associated with Clostridium difficile infection. Rev Gastroenterol Mex. 2017; 82:301‑308.

  17. Janarthanan S, Ditah I, Adler DG, Ehrinpreis MN. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol. 2012;107:1001-1010.

  18. Leibovici-Weissman Y, Atamna A, Schlesinger A, Eliakim-Raz N, Bishara J, Yahav D. Risk factors for short-term and long-term mortality in very old patients with Clostridium difficile infection: a retrospective study. Geriatr Gerontol Int. 2017;17:1378-1383.

  19. Shapiro DS, Friedmann R, Husseini A, Ivgi H, Yinnon AM, Assous MV. Can procalcitonin contribute to the diagnosis of Clostridium difficile colitis? Isr Med Assoc J. 2017;19:313-316.

  20. Dazley J, Shaaban H, Afridi S, Slim J. The role of procalcitonin levels in assessing the severity of Clostridium difficile infection. J Glob Infect Dis. 2015;7:120-121.

  21. Gardilcic M, Fica A, Chang M, Llanos C, Luzoro A. Diarrea asociada a Clostridium difficile en un hospital de adultos: estudio descriptivo. Rev Chil Infectol. 2000;17:307-312.




2020     |     www.medigraphic.com